INS and diabetes mellitus: According to the World Health Organization, diabetes—a long-term condition characterized by the body’s inability to produce sufficient insulin or use it efficiently, leading to high blood sugar levels—has seen its global prevalence double from 7% in 1990 to 14% in 2022, with over 800 million people affected [3].